The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Ipi Maintenance Phase

Forums Caregiver Community Ipi Maintenance Phase

  • Post
    Gene_S
    Participant

      Tomorrow, Gene goes for another maintenance dose of IPI/Yervoy (10mg/kg) with the GM-CSF injections that he does daily for two weeks on and 1 week off and then the 3rd of February will be more scans.

      We are hoping that this will put him at NED (no evidence of disease) and he can finally stop the infustions.  The first of March will be one year since he started on this clinical trial.

      Judy (loving wife and caregiver of Gene Stage IV)

      Tomorrow, Gene goes for another maintenance dose of IPI/Yervoy (10mg/kg) with the GM-CSF injections that he does daily for two weeks on and 1 week off and then the 3rd of February will be more scans.

      We are hoping that this will put him at NED (no evidence of disease) and he can finally stop the infustions.  The first of March will be one year since he started on this clinical trial.

      Judy (loving wife and caregiver of Gene Stage IV)

    Viewing 8 reply threads
    • Replies
        deardad
        Participant

          Hoping for NED for you too.

          All the best

          Nahmi from Melbourne

          deardad
          Participant

            Hoping for NED for you too.

            All the best

            Nahmi from Melbourne

            deardad
            Participant

              Hoping for NED for you too.

              All the best

              Nahmi from Melbourne

              FormerCaregiver
              Participant

                Yervoy and GM-CSF appear to be a very promising combination. Hope that NED will be the result.

                Take care

                Frank from Australia

                FormerCaregiver
                Participant

                  Yervoy and GM-CSF appear to be a very promising combination. Hope that NED will be the result.

                  Take care

                  Frank from Australia

                  FormerCaregiver
                  Participant

                    Yervoy and GM-CSF appear to be a very promising combination. Hope that NED will be the result.

                    Take care

                    Frank from Australia

                    CLPrice31
                    Participant

                      Looking forward to hearing happy scan results from you. Best of luck.

                      CLPrice31
                      Participant

                        Looking forward to hearing happy scan results from you. Best of luck.

                        CLPrice31
                        Participant

                          Looking forward to hearing happy scan results from you. Best of luck.

                      Viewing 8 reply threads

                      Tagged: 

                      • You must be logged in to reply to this topic.
                      About the MRF Patient Forum

                      The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                      The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                      Popular Topics